{"product_id":"global-markets-for-bioengineered-protein-drugs","title":"Global Markets for Bioengineered Protein Drugs","description":"\u003cp\u003eGlobal Markets for Bioengineered Protein Drugs\u003c\/p\u003e\n\n\u003cp\u003eReport Scope:\u003c\/p\u003e\n\n\u003cp\u003eThis report aims to provide a comprehensive study of the global market for bioengineered protein drugs, both in terms of quantitative and qualitative data, to help readers develop business\/growth strategies, assess the market landscape, analyze their position in the current marketplace and make informed business decisions regarding bioengineered protein drugs. Segmentation is based on the drug type, disease type, and region.\u003c\/p\u003e\n\n\u003cp\u003eIndustry growth drivers, restraints, trends, and opportunities in bioengineered protein drugs are also discussed in detail. The report also provides information on the bioengineered protein drug market competitive landscape, features detailed company profiles, and discusses the impact of COVID-19 on the market.\u003c\/p\u003e\n\n\u003cp\u003eReport Includes:\u003c\/p\u003e\n\n\u003cp\u003e28 data tables and 23 additional tables\u003c\/p\u003e\n\n\u003cp\u003eAn up-to-date overview and analysis of the global markets for bioengineered protein drugs\u003c\/p\u003e\n\n\u003cp\u003eAnalyses of the global market trends, with historic market revenue data (sales figures) from 2019-2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2027\u003c\/p\u003e\n\n\u003cp\u003eHighlights of the emerging technology trends, opportunities and gaps estimating current and future demand for bioengineered protein drugs market, and major regions and countries involved in market developments\u003c\/p\u003e\n\n\u003cp\u003eEstimation of the actual market size and revenue forecast for global bioengineered protein drugs market in USD million terms, and corresponding market share analysis by drug type, disease type, and region\u003c\/p\u003e\n\n\u003cp\u003eIn-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, future prospects, and contributions to the overall biopharmaceutical industry\u003c\/p\u003e\n\n\u003cp\u003eDiscussion of the regulatory aspects and standards for bioengineered protein therapeutics, newly approved products, underlying clinical trials for all phases and list of vaccines, and the COVID-19 impact on the progress of this market\u003c\/p\u003e\n\n\u003cp\u003eInsight into the recent industry structure, competitive aspects of each product segment, increasing investment on R\u0026amp;D activities to develop new and improved therapies, market development strategies, and company value share analysis\u003c\/p\u003e\n\n\u003cp\u003eIdentification of the major companies involved in the production and modification of protein drugs, and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues\u003c\/p\u003e\n\n\u003cp\u003eDescriptive company profiles of the leading global players, including AbbVie Inc., AstraZeneca plc, GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMS) Co., Pfizer Inc., Merck and Co., and Sanofi S.A.\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eABBVIE INC.\u003cbr\u003e\nADMA BIOLOGICS INC.\u003cbr\u003e\nAMGEN INC.\u003cbr\u003e\nASTRAZENECA PLC\u003cbr\u003e\nBAYER PHARMACEUTICALS\u003cbr\u003e\nBioNTech SE\u003cbr\u003e\nBRISTOL-MYERS SQUIBB\u003cbr\u003e\nCSL LTD.\u003cbr\u003e\nELI LILLY AND CO.\u003cbr\u003e\nF. Hoffmann-La Roche AG\u003cbr\u003e\nGLAXOSMITHKLINE PLC\u003cbr\u003e\nGRIFOLS S.A.\u003cbr\u003e\nJOHNSON \u0026amp; JOHNSON\u003cbr\u003e\nMERCK \u0026amp; CO., INC.\u003cbr\u003e\nNOVARTIS AG\u003cbr\u003e\nNOVO NORDISK A\/S\u003cbr\u003e\nOCTAPHARMA AG\u003cbr\u003e\nPFIZER INC.\u003cbr\u003e\nREGENERON PHARMACEUTICALS INC.\u003cbr\u003e\nSANOFI\u003cbr\u003e\nTAKEDA PHARMACEUTICAL CO., LTD.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"March, 2023 \/ 185 Pages \/ MCW16228696","offer_id":47646878269746,"sku":null,"price":6600.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-markets-for-bioengineered-protein-drugs","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}